Intraperitoneal alpha-interferon alternating with cisplatin in residual ovarian carcinoma: a phase II Gynecologic Oncology Group study. [electronic resource]
Producer: 19990816Description: 48-52 p. digitalISSN:- 0090-8258
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cisplatin -- administration & dosage
- Female
- Humans
- Infusions, Parenteral
- Interferon-alpha -- administration & dosage
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Ovarian Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.